Literature DB >> 22795527

Differentiation of brain metastases by percentagewise quantification of intratumoral-susceptibility-signals at 3Tesla.

Alexander Radbruch1, Markus Graf, Linda Kramp, Benedikt Wiestler, Ralf Floca, Philipp Bäumer, Matthias Roethke, Bram Stieltjes, Heinz-Peter Schlemmer, Sabine Heiland, Martin Bendszus.   

Abstract

INTRODUCTION: Evaluation of intratumoral-susceptibility-signals (ITSS) in susceptibility-weighted-imaging (SWI) has been reported to improve diagnostic performance for solitary enhancing brain lesions. Due to the distinct morphologic variability of ITSS, standardized evaluation proved to be difficult. We analyzed, if a new postprocessing method using percentagewise quantification (PQ) of ITSS enables differentiation between different entities of cerebral metastases and may thus improve differential diagnosis in cases of unknown primary.
MATERIALS AND METHODS: SWI and contrast enhanced T1-weighted MR images were acquired from 84 patients with intracerebral metastases (20 patients with mamma carcinoma (MC), 15 patients with malignant melanoma (MM), 49 patients with bronchial carcinoma (BC)) at 3Tesla MR. Images were co-registered and enhancing lesions were delineated on T1-weighted images and the outline transferred to the corresponding SWI map. All voxels within the lesion presenting values below a reference value placed in the ventricular system were determined and percentagewise calculated.
RESULTS: Diagnostic performance of percentagewise quantification (PQ) of ITSS, as determined with area under the receiver operating characteristic curve (AUC) was excellent (AUC=0.96; 95% confidence interval (CI) 0.90, 1.00) to discriminate MM from MC, good for the discrimination of MM and BC (AUC=0.81, 95% CI 0.70, 0.92) and poor for the discrimination of MC and BC (AUC=0.60; 95% CI 0.47, 0.73).
CONCLUSION: PQ is a new approach for the assessment of SWI that can be used for differential diagnosis of intracerebral metastases. Metastases of MM and MC or BC can be distinguished with high sensitivity and specificity.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22795527     DOI: 10.1016/j.ejrad.2012.06.016

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  11 in total

Review 1.  [Principles and applications of susceptibility weighted imaging].

Authors:  F T Kurz; M Freitag; H-P Schlemmer; M Bendszus; C H Ziener
Journal:  Radiologe       Date:  2016-02       Impact factor: 0.635

2.  Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma.

Authors:  Ana Marija Franceschi; Stergios J Moschos; Carey K Anders; Samuel Glaubiger; Frances A Collichio; Carrie B Lee; Mauricio Castillo; Yueh Z Lee
Journal:  J Comput Assist Tomogr       Date:  2016 Sep-Oct       Impact factor: 1.826

Review 3.  Brain metastases: neuroimaging.

Authors:  Whitney B Pope
Journal:  Handb Clin Neurol       Date:  2018

4.  [Towards more precision in the therapy of brain tumors. Possibilities and limits of MRI].

Authors:  A Radbruch; E Hattingen
Journal:  Nervenarzt       Date:  2015-06       Impact factor: 1.214

Review 5.  Introduction to Quantitative Susceptibility Mapping and Susceptibility Weighted Imaging.

Authors:  Pascal P R Ruetten; Jonathan H Gillard; Martin J Graves
Journal:  Br J Radiol       Date:  2019-07-26       Impact factor: 3.039

6.  [Application of ultrahigh-field MRI in neuro-oncology].

Authors:  A Radbruch; H-P Schlemmer
Journal:  Radiologe       Date:  2013-05       Impact factor: 0.635

7.  [Cerebral MR imaging of malignant melanoma].

Authors:  M Breckwoldt; M Bendszus
Journal:  Radiologe       Date:  2015-02       Impact factor: 0.635

8.  Intra-tumoral susceptibility signal: a post-processing technique for objective grading of astrocytoma with susceptibility-weighted imaging.

Authors:  Tzu-Chao Chuang; Yen-Lin Chen; Wan-Pin Shui; Hsiao-Wen Chung; Shu-Shong Hsu; Ping-Hong Lai
Journal:  Quant Imaging Med Surg       Date:  2022-01

Review 9.  Advanced MR Imaging in Neuro-oncology.

Authors:  A Radbruch; M Bendszus
Journal:  Clin Neuroradiol       Date:  2015-07-29       Impact factor: 3.649

10.  The susceptibility ring.

Authors:  Darshana Sanghvi; Ajinkya Redij; Mihir Munshi; Vasav Nakshiwala
Journal:  Br J Radiol       Date:  2019-07-09       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.